Which blockbuster is GSK gunning for next? CEO Miels is looking to oncology Read more →

GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program Read more →

FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting Read more →